Proud to see our CEO, Nicolas Mario, share his expertise at the 2026 PSMA & Beyond Conference UCLA.

His insights into raw material and enrichment technology constraints clarify for the medical community just how complex the journey is from the beginning of the supply chain to the patient’s dose.

At MEDraysintell, we are committed to supporting the growth of nuclear medicine with robust market and clinical data, foresight, and actionable intelligence.